Status:
COMPLETED
Efficacy of Resistive Capacitive Monopolar Radiofrequency in the Physiotherapeutic Treatment of Chronic Pelvic Pain: RCT
Lead Sponsor:
RAPbarcelona
Conditions:
Pelvic Pain
Pelvic Pain Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates if the application of resistive capacitive monopolar radiofrequency therapy associated with physiotherapeutic techniques and pain education provides benefits with respect to physi...
Detailed Description
It is evident that physiotherapeutic techniques and pain education are a first-line treatment for patients suffering from chronic pelvic pain. But there is no scientific evidence that resistive capaci...
Eligibility Criteria
Inclusion
- Have an age equal to or greater than 18 years
- Having chronic pelvic pain of six or more months of evolution.
Exclusion
- Failure to grant informed consent.
- Have fibromyalgia.
- Present a pacemaker or other type of electronic implant.
- Suffer systemic diseases (infectious, vascular, endocrine, metabolic or neoplastic conditions).
- Previous treatment with chemotherapy and / or radiotherapy in the pelvic area.
- Suffering from neuromuscular diseases (amyotrophic lateral sclerosis, multiple sclerosis, myasthenia gravis or spinal muscular atrophy).
- Have myelopathy and osteomyelitis.
- Have neurological and / or metabolic pathology that alters the response capacity: diabetes, parkinson's disease, senile dementia ...
- Have an alteration of the central nervous system (traumatic or spinal vascular injury)
- Suffer oncological processes with sacral involvement.
- Have a severe mental disorder.
- Have vulvodynia
- Be pregnant.
- Have undergone surgery in the last 3 months in the pelvic area.
- Have hypersensitivity of the skin, hyposensitivity and / or rejection of manual contact.
- Inability to correctly complete the questionnaires or understand the study protocol.
- Having initiated other pelvic physiotherapy treatments during the study intervention.
Key Trial Info
Start Date :
March 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 23 2021
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT03797911
Start Date
March 23 2019
End Date
April 23 2021
Last Update
December 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andrea Carralero Martinez
Barcelona, Spain, 08004